T. Bondurant French - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock T. Bondurant French’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Data Integration,
- Cybersecurity,
- Women Founded,
- CRM,
- Life Science,
- Artificial Intelligence (AI),
- Information Services,
- Information Technology (IT),
- Analytics,
- Biotechnology,
- Electronic Health Records (EHR),
- Employee Benefits,
- Hardware,
- Insurance,
- Medical,
- Therapeutics,
- Machine Learning,
- Pharmaceuticals
Social media:
Past investments:
- Arctic Wolf
- Lever
- Snow Software
- Partner Therapeutics
- Homeward
- Sauce Labs
- Spiceworks
- Dynamic Signal
- Neuraltus Pharmaceuticals
- Five9
- VillageMD
- ThreatMetrix
- Atlantis Computing
- healthfinch
- MATRIXX Software
- Orbus Therapeutics
- Corvus Pharmaceuticals
- Smule
- Naurex
- Aptinyx
- MyHealthTeams
- Redox
- SymphonyRM
- ServiceMax
- Scytl
- Maxwell Health
- CareCloud
- Cirius Therapeutics
- Cybera
- GoCardless
- Epirium Bio
- Outpost Medicine
- ThreatQuotient
- Couchbase
- Advise Insurance
- Bluprint
- cbanc Network
- TurnKey Vacation Rentals
- Palvella Therapeutics
- Tripping.com
- Borderfree
- Solera Health
- Q2ebanking
- Chrome River Technologies
- Atox Bio
- Visier
- Icosavax
- Millendo Therapeutics
- RadiumOne
- TeleSign
- PerimeterX
- LogRhythm
- Lyra Health
- Apto
- Damballa
- Criteo
- Hightail
- Aircall
- Qpex Biopharma
- Mintigo
- Punchh
- Fusion Pharmaceuticals
- TrendKite
- BoomTown
- Boundary
Investor Profile
T. Bondurant French is a Private Equity Firm based in Chicago, Illinois, United States with a diverse investment portfolio that includes companies such as Arctic Wolf, Lever, Snow Software, Partner Therapeutics, Homeward, Sauce Labs, Spiceworks, Dynamic SignalNeuraltus Pharmaceuticals, Five9, VillageMD, ThreatMetrix, Atlantis Computing, healthfinch, MATRIXX Software, Orbus Therapeutics, Corvus Pharmaceuticals, Smule, Naurex, Aptinyx, MyHealthTeams, Redox, SymphonyRM, ServiceMax, Scytl, Maxwell Health, CareCloud, Cirius Therapeutics, Cybera, GoCardless, Epirium Bio, Outpost Medicine, ThreatQuotient, Couchbase, Advise Insurance, Bluprint, cbanc Network, TurnKey Vacation Rentals, Palvella Therapeutics, Tripping.com, Borderfree, Solera Health, Q2ebanking, Chrome River Technologies, Atox Bio, Visier, Icosavax, Millendo Therapeutics, RadiumOne, TeleSign, PerimeterX, LogRhythm, Lyra Health, Apto, Damballa, Criteo, Hightail, Aircall, Qpex Biopharma, Mintigo, Punchh, Fusion Pharmaceuticals, TrendKite, BoomTown, Boundary, . Over time, T. Bondurant French has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether T. Bondurant French is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Data Integration, Cybersecurity, Women Founded, CRM, Life Science, Artificial Intelligence (AI), Information Services, Information Technology (IT), Analytics, Biotechnology, Electronic Health Records (EHR), Employee Benefits, Hardware, Insurance, Medical, Therapeutics, Machine Learning, Pharmaceuticals may find it worthwhile to explore potential connections with T. Bondurant French, as their portfolio suggests a familiarity and interest in this area.
Understanding T. Bondurant French’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
